Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120842825 | 12084282 | 5 | F | 20160727 | 20160217 | 20160803 | PER | US-ELI_LILLY_AND_COMPANY-US201602001128 | ELI LILLY AND CO | 0.00 | F | Y | 104.00000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120842825 | 12084282 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK UNK, UNKNOWN | U | U | 21368 | TABLET | |||||||
120842825 | 12084282 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | Oral | 10 MG, QD | 1500226A | 0 | 10 | MG | QD | ||||||
120842825 | 12084282 | 3 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1504767A | 0 | 10 | MG | QD | ||||||
120842825 | 12084282 | 4 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 13.75 MG, TID | U | U | 2100397 | 0 | 13.75 | MG | TABLET | TID | |||
120842825 | 12084282 | 5 | SS | ORENITRAM | TREPROSTINIL | 1 | Unknown | 14 MG, TID | U | U | 0 | 14 | MG | TABLET | TID | ||||
120842825 | 12084282 | 6 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | UNK UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
120842825 | 12084282 | 1 | Product used for unknown indication |
120842825 | 12084282 | 2 | Product used for unknown indication |
120842825 | 12084282 | 4 | Pulmonary arterial hypertension |
120842825 | 12084282 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
120842825 | 12084282 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
120842825 | 12084282 | Cough | |
120842825 | 12084282 | Diarrhoea | |
120842825 | 12084282 | Dizziness | |
120842825 | 12084282 | Dyspnoea at rest | |
120842825 | 12084282 | Dyspnoea exertional | |
120842825 | 12084282 | Flushing | |
120842825 | 12084282 | Malaise | |
120842825 | 12084282 | Oropharyngeal pain | |
120842825 | 12084282 | Pain in extremity | |
120842825 | 12084282 | Palpitations | |
120842825 | 12084282 | Peripheral swelling | |
120842825 | 12084282 | Pneumonia | |
120842825 | 12084282 | Sinus disorder | |
120842825 | 12084282 | Skin hyperpigmentation | |
120842825 | 12084282 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
120842825 | 12084282 | 2 | 20130823 | 0 | ||
120842825 | 12084282 | 4 | 20150819 | 0 |